Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 1
2009 2
2010 6
2011 5
2012 7
2013 13
2014 12
2015 14
2016 9
2017 11
2018 17
2019 15
2020 17
2021 17
2022 22
2023 11
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Multicenter PET image harmonization using generative adversarial networks.
Haberl D, Spielvogel CP, Jiang Z, Orlhac F, Iommi D, Carrió I, Buvat I, Haug AR, Papp L. Haberl D, et al. Among authors: haug ar. Eur J Nucl Med Mol Imaging. 2024 May 2. doi: 10.1007/s00259-024-06708-8. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38696130
Comparison of discovery rates and prognostic utility of [68Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer-a cross-sectional study.
Kluge K, Einspieler H, Haberl D, Spielvogel C, Amereller D, Egger G, Kramer G, Grubmüller B, Shariat S, Hacker M, Kenner L, Haug A. Kluge K, et al. Among authors: haug a. Eur J Nucl Med Mol Imaging. 2024 May 2. doi: 10.1007/s00259-024-06698-7. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38693454
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.
Schürrle SB, Eberlein U, Ansquer C, Beauregard JM, Durand-Gasselin L, Grønbæk H, Haug A, Hicks RJ, Lenzo NP, Navalkissoor S, Nicolas GP, Pais B, Volteau M, Wild D, McEwan A, Lassmann M. Schürrle SB, et al. Among authors: haug a. Eur J Nucl Med Mol Imaging. 2024 Mar 26. doi: 10.1007/s00259-024-06682-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38528164
Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study.
Spielvogel CP, Haberl D, Mascherbauer K, Ning J, Kluge K, Traub-Weidinger T, Davies RH, Pierce I, Patel K, Nakuz T, Göllner A, Amereller D, Starace M, Monaci A, Weber M, Li X, Haug AR, Calabretta R, Ma X, Zhao M, Mascherbauer J, Kammerlander A, Hengstenberg C, Menezes LJ, Sciagra R, Treibel TA, Hacker M, Nitsche C. Spielvogel CP, et al. Among authors: haug ar. Lancet Digit Health. 2024 Apr;6(4):e251-e260. doi: 10.1016/S2589-7500(23)00265-0. Lancet Digit Health. 2024. PMID: 38519153 Free article.
Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms.
Melhorn P, Mazal P, Wolff L, Popov P, Kretschmer-Chott E, Haug A, Mayerhoefer ME, Raderer M, Kiesewetter B. Melhorn P, et al. Among authors: haug a. Endocr Relat Cancer. 2024 Jan 31;31(3):e230151. doi: 10.1530/ERC-23-0151. Print 2024 Mar 1. Endocr Relat Cancer. 2024. PMID: 38214923
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
Werner R, Haug A, Buske C, Heidegger S, Illert AL, Bassermann F, Herhaus P, Buck A, Duell J, Topp MS, Kraus S, Einsele H, Lapa C, Raderer M, Lenz G, Habringer S, von Tresckow B, Keller U. Werner R, et al. Among authors: haug a. Nuklearmedizin. 2024 Apr;63(2):57-61. doi: 10.1055/a-2194-9965. Epub 2024 Jan 8. Nuklearmedizin. 2024. PMID: 38190998 Free PMC article.
Deep learning for [18F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysis.
Häggström I, Leithner D, Alvén J, Campanella G, Abusamra M, Zhang H, Chhabra S, Beer L, Haug A, Salles G, Raderer M, Staber PB, Becker A, Hricak H, Fuchs TJ, Schöder H, Mayerhoefer ME. Häggström I, et al. Among authors: haug a. Lancet Digit Health. 2024 Feb;6(2):e114-e125. doi: 10.1016/S2589-7500(23)00203-0. Epub 2023 Dec 21. Lancet Digit Health. 2024. PMID: 38135556 Free PMC article.
Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective-Prospective [68Ga]Ga-PSMA-11 PET/CT Study.
Kluge K, Einspieler H, Haberl D, Spielvogel C, Stoiber S, Vraka C, Papp L, Wunsch S, Egger G, Kramer G, Grubmüller B, Shariat S, Hacker M, Kenner L, Haug A. Kluge K, et al. Among authors: haug a. J Nucl Med. 2024 Jan 2;65(1):63-70. doi: 10.2967/jnumed.123.266158. J Nucl Med. 2024. PMID: 38050125 Free PMC article.
Metabolic tumor volume and sites of organ involvement predict outcome in NSCLC immune-checkpoint inhibitor therapy.
Kifjak D, Hochmair M, Sobotka D, Haug AR, Ambros R, Prayer F, Heidinger BH, Roehrich S, Milos RI, Wadsak W, Fuereder T, Krenbek D, Fazekas A, Meilinger M, Mayerhoefer ME, Langs G, Herold C, Prosch H, Beer L. Kifjak D, et al. Among authors: haug ar. Eur J Radiol. 2024 Jan;170:111198. doi: 10.1016/j.ejrad.2023.111198. Epub 2023 Nov 21. Eur J Radiol. 2024. PMID: 37992608 Free article.
170 results